NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants.
Int J Cancer
; 125(2): 308-17, 2009 Jul 15.
Article
in En
| MEDLINE
| ID: mdl-19378338
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
/
Genes, abl
/
NF-kappa B
/
Apoptosis
/
Mutation
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Int J Cancer
Year:
2009
Document type:
Article
Affiliation country:
France
Country of publication:
United States